During the past decade, T.B. Bond Pharmacy conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "T.B. Bond Pharmacy" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "McNeil AB" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "T.B. Bond Pharmacy" are "Frequent Heartburn" (1 trials), "Hypercholesterolemia" (1 trials), "Tobacco Dependence" (1 trials) and "Urological Manifestations" (1 trials). Many other conditions were trialed in "T.B. Bond Pharmacy" in a lesser frequency.

Most popular intervention types in "T.B. Bond Pharmacy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin calcium 10 mg" (1 trials), "Nicotine" (1 trials), "Placebo" (1 trials), "Rabeprazole sodium" (1 trials) and "tamsulosin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "T.B. Bond Pharmacy" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "T.B. Bond Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in T.B. Bond Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in T.B. Bond Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".